World Brain Tumour Day: Why Glioblastoma Is So Hard to Treat

Only around 5 to 10 percent of people with glioblastoma are still alive five years after diagnosis, despite maximal standard therapy. This figure stays with us, because behind it lie life stories, families, and hopes that are put at stake every single day.

World Brain Tumour Day is a reminder of how urgently we need new, more effective therapies against brain tumours, and how important it is to support patients and their families.

What makes glioblastoma so difficult to treat is its biology. Certain tumour cells are especially resistant to radiation and chemotherapy. They survive standard therapy and are considered the main cause of the tumour's recurrence. Targeting these cells precisely is one of the most important open questions in neuro-oncology and one of the greatest challenges in therapy development.

At BioIntelligence, we work together with innovative start-up teams such as GliTTher to turn excellent research into better therapies, for more time and quality of life for people with brain tumours.